Download
  Back
2010/11/15 6:00 PM

Néovacs authorized to proceed to the fourth dose level of IFNα-Kinoid in the phase I/II trial in lupus

Information only available in PDF version.

This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: m21xY5lnZZiUyJqdZ8tua2ljmm5impSamGGalpVslJyXbnKRyW+TbZqeZm9onmlr
- Check this key: https://www.security-master-key.com.
  Download
  Back

Each PDF has been scanned by antimalware and incorporates a SECURITY MASTER Footprint. To check its authenticity:
www.security-master-footprint.com

Party powered automatically by Actusnews Wire ©
(Primary Information Provider)